SG Americas Securities’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-281,007
Closed -$8.23M 3909
2017
Q3
$8.23M Buy
281,007
+273,801
+3,800% +$7.67M 0.07% 204
2017
Q2
$189K Buy
7,206
+2,047
+40% +$50.3K ﹤0.01% 2479
2017
Q1
$121K Buy
+5,159
New +$127K ﹤0.01% 2853
2016
Q4
Sell
-5,478
Closed -$154K 3670
2016
Q3
$154K Buy
+5,478
New +$140K ﹤0.01% 2717
2015
Q4
Sell
-3,525
Closed -$100K 3153
2015
Q3
$100K Sell
3,525
-68
-2% -$2.29K ﹤0.01% 1883
2015
Q2
$120K Buy
+3,593
New +$110K ﹤0.01% 2262
2015
Q1
Sell
-7,381
Closed -$153K 3305
2014
Q4
$153K Sell
7,381
-3,596
-33% -$85.4K ﹤0.01% 2630
2014
Q3
$268K Buy
+10,977
New +$291K ﹤0.01% 1839

SG Americas Securities's PMC Position: Q4 2017 in Review

SG Americas Securities sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 281,007 shares — an estimated $8.23M sold.

SG Americas Securities first reported a position in PMC in Q3 2014 and held it in 8 quarters. The position peaked at $8.23M in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

  • SG Americas Securities reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
  • SG Americas Securities sold 281,007 PharMerica Corporation shares in Q4 2017, an estimated $8.23M.
  • SG Americas Securities first reported a position in PharMerica Corporation in Q3 2014 and held it in 8 quarters.
  • SG Americas Securities's PharMerica Corporation position peaked at $8.23M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on SG Americas Securities's 13F filing for Q4 2017, filed 24 Jan 2018.